US2008227204A1PendingUtilityA1

Process for producing cytotoxic lymphocyte

59
Assignee: TAKARA BIO INCPriority: Mar 25, 2002Filed: Jul 31, 2007Published: Sep 18, 2008
Est. expiryMar 25, 2022(expired)· nominal 20-yr term from priority
A61P 37/02A61P 35/00A61P 31/12A61P 37/04A61K 2035/124C12N 2510/00C12N 2501/58C12N 2533/52A61K 35/17A61K 40/11A61K 40/15C12N 5/0638A61K 40/46A61K 40/42C12N 5/0636A61P 31/04
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a method for preparing a cytotoxic lymphocyte characterized in that the method comprises the step of carrying out at least one of induction, maintenance and expansion of a cytotoxic lymphocyte in the presence of fibronectin, a fragment thereof or a mixture thereof.

Claims

exact text as granted — not AI-modified
1 . A cell culture medium comprising an anti-CD3 antibody and an effective ingredient selected from the group consisting of fibronectin, a fragment thereof and a mixture thereof. 
     
     
         2 . The medium according to  claim 1 , wherein said anti-CD3 antibody and/or said effective ingredient are immobilized to a solid phase. 
     
     
         3 . The medium according to  claim 2 , wherein the solid phase is a petri dish, a flask, a bag, beads, a membrane or a glass slide. 
     
     
         4 . The medium according to  claim 1 , wherein said fibronectin fragment comprises at least one domain selected from the group consisting of a VLA-4 binding domain, a VLA-5 binding domain and a heparin binding domain. 
     
     
         5 . The medium according to  claim 1 , further comprising IL-2. 
     
     
         6 . A method of cultivating a cell, wherein said method comprises incubating a cell in the medium according to  claim 1 .

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.